Send mail to Author

A novel 2-metagene signature to identify high-risk HNSCC patients amongst those who are clinically at intermediate risk and are treated with PORT (Article)

Please indicate your contact information and select, which author you want to contact.



 
 _    _    __   __   _    _    __   __     _____    _____   
| |  | ||  \ \\/ // | || | ||  \ \\/ //   / ___//  |  ___|| 
| |/\| ||   \ ` //  | || | ||   \ ` //    \___ \\  | ||__   
|  /\  ||    | ||   | \\_/ ||    | ||     /    //  | ||__   
|_// \_||    |_||    \____//     |_||    /____//   |_____|| 
`-`   `-`    `-`'     `---`      `-`'   `-----`    `-----`
 


Back to frontdoor view

OPUS4 Logo